YUVIPTA

Serial Number 98907719
802

Registration Progress

Application Filed
Dec 17, 2024
Under Examination
Approved for Publication
Jul 8, 2025
Published for Opposition
Jul 8, 2025
Registered

Trademark Image

YUVIPTA

Basic Information

Serial Number
98907719
Filing Date
December 17, 2024
Published for Opposition
July 8, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
802
Status Date
Aug 7, 2025
Application
Pending
Classes
005

Rights Holder

Insmed Incorporated

03
Address
700 Route 202/206
Bridgewater, NJ 08807

Ownership History

Insmed Incorporated

Original Applicant
03
Bridgewater, NJ

Insmed Incorporated

Owner at Publication
03
Bridgewater, NJ

Legal Representation

Attorney
Vincent J. Badolato

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

13 events
Date Code Type Description Documents
Aug 7, 2025 ETOF T EXTENSION OF TIME TO OPPOSE RECEIVED Loading...
Jul 8, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jul 8, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 2, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jun 6, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 4, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 10, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Mar 10, 2025 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Mar 10, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Mar 10, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Dec 17, 2024 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Dec 17, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Dec 17, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment and prevention of pulmonary diseases and conditions; Pharmaceutical preparations for the treatment of metastasis; Pharmaceutical preparations for the treatment and prevention of rheumatoid arthritis; Pharmaceutical preparations for the treatment and prevention of neutrophil-mediated diseases and conditions; Pharmaceutical preparations for the treatment and prevention of behcet disease; Pharmaceutical preparations for the treatment and prevention of inflammatory bowel disease; Pharmaceutical preparations for the treatment and prevention of rhinitis; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the treatment and prevention of lung diseases and conditions; Pharmaceutical preparations for the treatment and prevention of kidney diseases and conditions

Classification

International Classes
005